Search

Start typing to see results...

  • Home
  • >
  • Stock Market
  • >
  • Zydus Lifesciences Ltd

Zydus Lifesciences Ltd share price and stock overview

Zydus Lifesciences Ltd (NSE: ZYDUSLIFE, BSE: 532321) operates in the Pharmaceuticals - Indian - Bulk Drugs & Formln sector. The stock has an ISIN of INE010B01027 and a face value of Rs 1. As of 28 September 2026, it trades at Rs (1,225.00) with a market capitalisation of Rs 119899.96 crore. Figures are live and subject to change.

Zydus Lifesciences Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln
NSE BSE
1,225.00 21.10 (1.75%) upARrowC
As on: 28-Sep-2026 , 11:42 AM
Market Cap(₹Cr) 119899.96
Book Value(₹Cr) 237.3008466
BSE Code : 532321 NSE Symbol : ZYDUSLIFE EPS(TTM) : 36.54 ISIN Demat : INE010B01027 P/E(TTM) : 32.9 Face Value(₹) : 1 Div & Yield % : 0.08

Today Market

Stock Performance

Today Market

Today's High

73,740.85

Todday's Low

72,832.08

Open at

73,734.83

Previous Close

73,895.74

Volumes

0.00

Avg Price

-926.89

Historical Performance

News

26 Sep 26
Zydus Lifesciences will halt trading for insiders ahead of September 2026 results
Zydus Lifesciences Limited will close its trading window for directors and designated persons and their immediate relatives from October 1, 2026, until 48 hours after the declaration of unaudited financial results for the quarter and half year ending September 30, 2026, as stated in a filing with the BSE Limited and National Stock Exchange of India Limited.
22 Sep 26
Zydus Lifesciences Ltd spurts 0.6%, up for fifth straight session
Zydus Lifesciences Ltd gained for a fifth straight session today. The stock is quoting at Rs 1168, up 0.
18 Sep 26
Zydus Lifesciences Ltd soars 1.71%, rises for third straight session
Zydus Lifesciences Ltd rose for a third straight session today. The stock is quoting at Rs 1154.
11 Sep 26
Zydus Lifesciences reaffirmed credit ratings including AAA/Stable and A1+ for bank facilities totaling Rs. 4,724 crore
Zydus Lifesciences Ltd announced on September 11, 2026, that CRISIL Ratings Limited reviewed and reaffirmed the credit ratings of its various instruments and facilities, as detailed in letters dated September 10, 2026, including a long term rating of CRISIL AAA/Stable and a short term rating of CRISIL A1+ for Various Bank Facilities amounting to Rs.

Historical Prices

Share Price Chart

Historical Share Price

From Date:
To Date:     
Date Open Price (₹) High Price(₹) Low Price(₹) Close Price(₹) Total Volume No of Trades Net Turnover(₹) NIFTY
25-09-26 1185.50 1208.60 1182.40 1203.90 1991779 50760 2384476852.00 23140.50
24-09-26 1169.80 1190.60 1161.60 1180.30 1965875 39301 2322558035.60 23063.10
23-09-26 1156.00 1175.00 1156.00 1170.10 1088359 24324 1269326263.40 23446.80
22-09-26 1161.00 1178.00 1160.00 1162.30 1243696 22915 1454170126.50 23329.00
21-09-26 1155.00 1173.50 1152.10 1161.00 864429 21058 1004323177.80 23414.30
18-09-26 1150.70 1167.30 1147.70 1160.00 2789186 56206 3228915177.20 23346.40
17-09-26 1103.50 1139.90 1100.10 1135.10 1086138 36569 1225273092.20 23270.60
16-09-26 1093.70 1113.30 1086.00 1107.50 689380 31785 760133897.60 23217.60
15-09-26 1120.10 1124.50 1099.00 1099.00 522672 27925 580418225.40 23118.60
11-09-26 1114.00 1135.50 1104.60 1119.10 1038797 23727 1166150499.70 23398.10
123...

Fundamentals

Company Valuation

Market Cap (₹cr)

119899.96

PE Ratio

32.9

PB Ratio

5.07

Dividend Yield

0.08

ROE

15.87

ROCE

15.90

Book Value (₹)

237.3008466

Face Value (₹)

1

Share Holding Pattern

Category of Shareholder No of Shares % Share Holdings Demat Shares Share Holders
plus  Promoter & Group
plus  Foreign
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 10000 0.00 10000 1
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 10000 0.00 10000 1
plus  Indian
Bodies Corporate-Indian (Promoter & Group) 17581 0.00 17581 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 267640 0.03 267640 9
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 747978452 74.99 747978452 2
Others 0 0.00 0 0
Sub Total 748263673 75.01 748263673 12
Total ShareHolding for Promoter & Group 748273673 75.01 748273673 13
plus   Publice Share Holding
plus  Institution
Government(Central / State) 17517 0.00 17517 3
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 43354 0.00 43354 6
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 68658237 6.88 68658237 633
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 59450834 5.96 59450834 18
Mutual Funds / UTI 51033115 5.12 51033115 38
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1940203 0.19 1940203 22
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 181143260 18.16 181143260 720
plus  Non Institution
Bodies Corporate 5956572 0.60 5956572 1011
Clearing Members 142076 0.01 142076 52
Directors & their Relatives 376693 0.04 376693 6
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 3438726 0.34 3431901 10233
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 1477252 0.15 1476502 4996
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7375146 0.74 7375146 6
Individuals holding nominal share capital up to Rs. 1 lakh 46984324 4.71 45834329 382085
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 196878 0.02 196878 17
Others 1694604 0.17 1694604 2
Sub Total 68086899 6.83 66929329 398518
Total Public Shareholding 249230159 24.99 248072589 399238
Total of Promoter & Public ShareHolding 997503832 100.00 996346262 399251
plus  Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total 997503832 100.00 996346262 399251

Financials (₹ in cr)

Consolidated Standalone
Year EndMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Net Sales27,148.4023,241.5019,547.4017,237.4015,265.20
OPM (%)26.2926.8824.6718.5317.85
OP7,137.706,246.304,823.103,193.902,725.40
Other Income509.50269.50284.10186.60224.70
PBIDT8,468.007,108.405,654.203,442.303,678.10
INTEREST438.90165.9081.20129.90127.00
PBDT8,029.106,942.505,573.003,312.403,551.10
PBT6,104.505,807.104,794.701,985.502,950.80
EO-516.60-219.60-14.20-604.20112.70
PBT after EO6,621.106,026.704,808.902,589.702,838.10
TAXES1,594.701,411.90977.50587.80511.70
PAT5,040.004,525.503,859.501,960.304,487.30
EPS50.0944.9738.1419.3043.83
Raw Material18.8218.8223.4323.9226.48
Power and Fuel1.531.621.972.102.06
Employee Cost16.2715.8416.0516.0415.95
Other Manufacturing Expenses0.000.000.000.000.00
Selling and Administration Expenses21.9119.1314.5615.6514.48
Miscellaneous Expenses-0.423.185.314.476.04
Revenue (Growth %) 16.8118.9013.4012.921.08
PBIDT (Growth %)19.1325.7264.26-6.4115.92
PAT (Growth %) 11.3717.2696.88-56.31110.32
PBIDT (Margin %)31.1930.5828.9319.9724.09
PAT (Margin %) 18.5619.4719.7411.3729.40

Balance Sheet (₹ in cr)

Particulars (Sources Of Funds)Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Share Capital 100.60100.60100.60101.20102.40102.40
Reserves Total 23571.1021089.5015615.9013538.2013138.1012642.10
Equity Share Warrants0.000.000.000.000.000.00
Equity Application Money0.000.000.000.000.000.00
Total Shareholders Funds23671.7021190.1015716.5013639.4013240.5012744.50
Secured Loans 2198.902149.500.000.00500.00994.40
Unsecured Loans 5243.406192.706178.304825.302164.702925.50
Total Debt7442.308342.206178.304825.302664.703919.90
Other Liabilities292.10265.60209.70166.20191.30179.20
Total Liabilities31406.1029797.9022104.5018630.9016096.5016843.60
APPLICATION OF FUNDS :
Gross Block 10293.708899.608677.407999.807675.607009.10
Less : Accumulated Depreciation 5209.804697.504308.003815.703339.702897.10
Less:Impairment of Assets0.000.000.000.000.000.00
Net Block 5083.904202.104369.404184.104335.904112.00
Lease Adjustment0.000.000.000.000.000.00
Capital Work in Progress621.201188.50633.90739.30384.00570.50
Producing Properties0.000.000.000.000.000.00
Investments 11478.1011491.507283.004879.305118.006470.60
Current Assets, Loans & Advances
Inventories 2177.801952.101687.301782.401926.301780.00
Sundry Debtors 8494.908161.804740.103505.302277.701903.80
Cash and Bank Balance734.20144.10414.40248.10302.60154.00
Loans and Advances 639.90820.201069.501420.802110.302193.90
Total Current Assets12046.8011078.207911.306956.606616.906031.70
Less : Current Liabilities and Provisions
Current Liabilities 2067.601869.101669.201539.301384.501401.70
Provisions 325.90504.30252.80199.10105.90111.00
Total Current Liabilities & Provisions2393.502373.401922.001738.401490.401512.70
Net Current Assets9653.308704.805989.305218.205126.504519.00
Miscellaneous Expenses not written off 0.000.000.000.000.000.00
Deferred Tax Assets174.70195.70179.90112.00136.60129.70
Deferred Tax Liability254.70341.30238.20306.30289.70237.00
Net Deferred Tax-80.00-145.60-58.30-194.30-153.10-107.30
Other Assets4649.604356.603887.203804.301285.201278.80
Total Assets31406.1029797.9022104.5018630.9016096.5016843.60
Contingent Liabilities5529.901394.30111.00319.901797.101503.90

Cash Flow (₹ in cr)

Yearly Cash FlowMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Financing Activities -1,709.80827.00-300.801,384.50-2,579.90
Investing Activities 586.20-1,959.30-1,831.80-4,503.60569.60
Net Cash Flow 148.60-54.10-132.30-5.10224.00
Operating Activities 1,272.201,078.202,000.303,114.002,234.30

Peers

Balance Sheet Financial Ratios Profit & Loss
Aarti Pharmalabs...

931.05

(-0.90%)
Accent Microcell...

681.00

(+0.91%)
Accretion Pharma...

196.10

(-3.54%)
Achyut Healthcar...

Advanced Enzyme ...

284.90

(-2.15%)
Akums Drugs & Ph...

808.50

(-1.35%)
Albert David Ltd

867.00

(-0.78%)
Alembic Pharmace...

855.50

(-0.96%)

Corporate Actions

Bonus Dividends Splits
DateCorporate ActionInformation
No Corporate Actions Announced

Board of Directors

Chairman & Chief Executive Officer
PRP
Pankaj R Patel
Chairman(Non Exe)&Dir(Non-Ind)
Executive
Functional Directors
SPP
Sharvil P Patel
Executive Director & MD
Exec.
GNN
Ganesh N Nayak
Executive Director
Exec.
Independent Directors
MP
Mukesh Patel
Non-Exec & Non-Independent Dir
Ind.
BKS
Bhadresh K Shah
Independent Non Exe. Director
Ind.
AAM
Akhil A. Monappa
Independent Non Exe. Director
Ind.
UK
Upsana Kamineni
Independent Non Exe. Director
Ind.
SPP
Shelina P. Parikh
Independent Non Exe. Director
Ind.
KSL
Kulin S Lalbhai
Independent Director
Ind.
Other Officials
DNS
Dhaval N Soni
Company Sec. & Compli. Officer
Board

Frequently Asked Questions

What is the NSE symbol and BSE code for Zydus Lifesciences Ltd? −

Zydus Lifesciences Ltd trades on NSE under ZYDUSLIFE and on BSE under code 532321. The ISIN is INE010B01027 and the face value is Rs 1.

What is the share price of Zydus Lifesciences Ltd today? +

As of 28 September 2026, Zydus Lifesciences Ltd trades at Rs 1,225.00, a change of 21.10 (1.75%) on the day. Prices are live and subject to change.

What is the market capitalisation of Zydus Lifesciences Ltd? +

As of 28 September 2026, Zydus Lifesciences Ltd has a market cap of about Rs 119899.96 crore. This figure is live and moves with the share price.

Is Zydus Lifesciences Ltd profitable? +

In March 2026, Zydus Lifesciences Ltd reported a profit after tax of Rs 5,040.00 crore. The wording switches to "a net loss of Rs X crore" when the figure is negative.

What is the PE ratio of Zydus Lifesciences Ltd? +

: As of 28 September 2026, the PE (TTM) for Zydus Lifesciences Ltd is 32.9 and the price-to-book ratio is 5.07. When the PE shows zero, state that PE TTM is currently not applicable and give the PB only.

Does Zydus Lifesciences Ltd pay a dividend? +

As of 28 September 2026, the dividend yield for Zydus Lifesciences Ltd is 0.08%. The wording switches to "does not currently pay a dividend" when the yield is zero.

What is the shareholding pattern of Zydus Lifesciences Ltd? +

As of the latest disclosed pattern, promoters hold 75.01% of Zydus Lifesciences Ltd. Public shareholding is 24.99%, including mutual funds at 5.12% and foreign institutional investors at 6.88%.

What were the latest annual financials of Zydus Lifesciences Ltd? +

In March 2026, Zydus Lifesciences Ltd reported net sales of Rs 27,148.40 crore, revenue growth of 16.81%, and earnings per share of Rs 50.09.